Advances in Neutron Capture Therapy:
Binary systems for the treatment of cancer potentially are among the most attractive of the new therapeutic modalities that currently are under investigation. The basicconcept is to selectivelydestroy malignantcells whileconcomitantlysparing normal tissue. Neutron capture therapy (NCT) is the binary...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
1993
|
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | Binary systems for the treatment of cancer potentially are among the most attractive of the new therapeutic modalities that currently are under investigation. The basicconcept is to selectivelydestroy malignantcells whileconcomitantlysparing normal tissue. Neutron capture therapy (NCT) is the binary system that has been the subject of the Fifth International Symposium on Neutron Capture Therapy, which was held September13-17, 1992, in Columbus, Ohio, undertheauspicesoftheInternational Society for Neutron Capture Therapy. Its objective was to bring together researchers from throughout the world and to provide a forum at which they could present the latest advances in the development of Neutron capture therapy. Neutron capture therapy has largely, but not exclusively, focused on the use of boron-10 as the target nuclide. Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when the stable isotope, boron-10, absorbs low-energy non ionizing thermal neutrons to yield alphaparticles and recoiling lithium-7 nuclei. The size and energy of these high linear energy transfer (LET) particles result in their being confined largely to the cells in which the capture reaction occurs. For BNCT to be successful, a sufficient numberof I~atoms mustbe localized within neoplastic cells, and enough thermal neutrons must be delivered and absorbed by the I~ to produce a lethal 1~(n,QVLi reaction. Two major problems must be surmounted |
| Beschreibung: | 1 Online-Ressource (XXX, 829 p) |
| ISBN: | 9781461529781 |
| DOI: | 10.1007/978-1-4615-2978-1 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046145782 | ||
| 003 | DE-604 | ||
| 005 | 20200316 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1993 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461529781 |9 978-1-4615-2978-1 | ||
| 024 | 7 | |a 10.1007/978-1-4615-2978-1 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4615-2978-1 | ||
| 035 | |a (OCoLC)1119015985 | ||
| 035 | |a (DE-599)BVBBV046145782 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.07 |2 23 | |
| 084 | |a YR 3505 |0 (DE-625)154104:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Advances in Neutron Capture Therapy |c edited by Albert H. Soloway, Rolf F. Barth, David E. Carpenter |
| 264 | 1 | |a Boston, MA |b Springer US |c 1993 | |
| 300 | |a 1 Online-Ressource (XXX, 829 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a Binary systems for the treatment of cancer potentially are among the most attractive of the new therapeutic modalities that currently are under investigation. The basicconcept is to selectivelydestroy malignantcells whileconcomitantlysparing normal tissue. Neutron capture therapy (NCT) is the binary system that has been the subject of the Fifth International Symposium on Neutron Capture Therapy, which was held September13-17, 1992, in Columbus, Ohio, undertheauspicesoftheInternational Society for Neutron Capture Therapy. Its objective was to bring together researchers from throughout the world and to provide a forum at which they could present the latest advances in the development of Neutron capture therapy. Neutron capture therapy has largely, but not exclusively, focused on the use of boron-10 as the target nuclide. Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when the stable isotope, boron-10, absorbs low-energy non ionizing thermal neutrons to yield alphaparticles and recoiling lithium-7 nuclei. The size and energy of these high linear energy transfer (LET) particles result in their being confined largely to the cells in which the capture reaction occurs. For BNCT to be successful, a sufficient numberof I~atoms mustbe localized within neoplastic cells, and enough thermal neutrons must be delivered and absorbed by the I~ to produce a lethal 1~(n,QVLi reaction. Two major problems must be surmounted | ||
| 650 | 4 | |a Pathology | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Nuclear Medicine | |
| 650 | 4 | |a Ultrasound | |
| 650 | 4 | |a Biochemistry, general | |
| 650 | 4 | |a Biotechnology | |
| 650 | 4 | |a Pathology | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Nuclear medicine | |
| 650 | 4 | |a Diagnosis, Ultrasonic | |
| 650 | 4 | |a Biochemistry | |
| 650 | 4 | |a Biotechnology | |
| 650 | 0 | 7 | |a Neutroneneinfangtherapie |0 (DE-588)4596398-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1992 |z Columbus Ohio |2 gnd-content | |
| 689 | 0 | 0 | |a Neutroneneinfangtherapie |0 (DE-588)4596398-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Soloway, Albert H. |4 edt | |
| 700 | 1 | |a Barth, Rolf F. |4 edt | |
| 700 | 1 | |a Carpenter, David E. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461362968 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306445675 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461529798 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-2978-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031525967 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4615-2978-1 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180482904031232 |
|---|---|
| any_adam_object | |
| author2 | Soloway, Albert H. Barth, Rolf F. Carpenter, David E. |
| author2_role | edt edt edt |
| author2_variant | a h s ah ahs r f b rf rfb d e c de dec |
| author_facet | Soloway, Albert H. Barth, Rolf F. Carpenter, David E. |
| building | Verbundindex |
| bvnumber | BV046145782 |
| classification_rvk | YR 3505 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4615-2978-1 (OCoLC)1119015985 (DE-599)BVBBV046145782 |
| dewey-full | 616.07 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.07 |
| dewey-search | 616.07 |
| dewey-sort | 3616.07 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4615-2978-1 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03602nmm a2200613zc 4500</leader><controlfield tag="001">BV046145782</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20200316 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1993 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461529781</subfield><subfield code="9">978-1-4615-2978-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-2978-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4615-2978-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119015985</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145782</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YR 3505</subfield><subfield code="0">(DE-625)154104:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in Neutron Capture Therapy</subfield><subfield code="c">edited by Albert H. Soloway, Rolf F. Barth, David E. Carpenter</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXX, 829 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Binary systems for the treatment of cancer potentially are among the most attractive of the new therapeutic modalities that currently are under investigation. The basicconcept is to selectivelydestroy malignantcells whileconcomitantlysparing normal tissue. Neutron capture therapy (NCT) is the binary system that has been the subject of the Fifth International Symposium on Neutron Capture Therapy, which was held September13-17, 1992, in Columbus, Ohio, undertheauspicesoftheInternational Society for Neutron Capture Therapy. Its objective was to bring together researchers from throughout the world and to provide a forum at which they could present the latest advances in the development of Neutron capture therapy. Neutron capture therapy has largely, but not exclusively, focused on the use of boron-10 as the target nuclide. Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when the stable isotope, boron-10, absorbs low-energy non ionizing thermal neutrons to yield alphaparticles and recoiling lithium-7 nuclei. The size and energy of these high linear energy transfer (LET) particles result in their being confined largely to the cells in which the capture reaction occurs. For BNCT to be successful, a sufficient numberof I~atoms mustbe localized within neoplastic cells, and enough thermal neutrons must be delivered and absorbed by the I~ to produce a lethal 1~(n,QVLi reaction. Two major problems must be surmounted</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ultrasound</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnosis, Ultrasonic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neutroneneinfangtherapie</subfield><subfield code="0">(DE-588)4596398-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1992</subfield><subfield code="z">Columbus Ohio</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Neutroneneinfangtherapie</subfield><subfield code="0">(DE-588)4596398-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soloway, Albert H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barth, Rolf F.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carpenter, David E.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461362968</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306445675</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461529798</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-2978-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525967</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-2978-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1992 Columbus Ohio gnd-content |
| genre_facet | Konferenzschrift 1992 Columbus Ohio |
| id | DE-604.BV046145782 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:28Z |
| institution | BVB |
| isbn | 9781461529781 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525967 |
| oclc_num | 1119015985 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XXX, 829 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Springer US |
| record_format | marc |
| spelling | Advances in Neutron Capture Therapy edited by Albert H. Soloway, Rolf F. Barth, David E. Carpenter Boston, MA Springer US 1993 1 Online-Ressource (XXX, 829 p) txt rdacontent c rdamedia cr rdacarrier Binary systems for the treatment of cancer potentially are among the most attractive of the new therapeutic modalities that currently are under investigation. The basicconcept is to selectivelydestroy malignantcells whileconcomitantlysparing normal tissue. Neutron capture therapy (NCT) is the binary system that has been the subject of the Fifth International Symposium on Neutron Capture Therapy, which was held September13-17, 1992, in Columbus, Ohio, undertheauspicesoftheInternational Society for Neutron Capture Therapy. Its objective was to bring together researchers from throughout the world and to provide a forum at which they could present the latest advances in the development of Neutron capture therapy. Neutron capture therapy has largely, but not exclusively, focused on the use of boron-10 as the target nuclide. Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when the stable isotope, boron-10, absorbs low-energy non ionizing thermal neutrons to yield alphaparticles and recoiling lithium-7 nuclei. The size and energy of these high linear energy transfer (LET) particles result in their being confined largely to the cells in which the capture reaction occurs. For BNCT to be successful, a sufficient numberof I~atoms mustbe localized within neoplastic cells, and enough thermal neutrons must be delivered and absorbed by the I~ to produce a lethal 1~(n,QVLi reaction. Two major problems must be surmounted Pathology Pharmacology/Toxicology Nuclear Medicine Ultrasound Biochemistry, general Biotechnology Toxicology Nuclear medicine Diagnosis, Ultrasonic Biochemistry Neutroneneinfangtherapie (DE-588)4596398-8 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1992 Columbus Ohio gnd-content Neutroneneinfangtherapie (DE-588)4596398-8 s DE-604 Soloway, Albert H. edt Barth, Rolf F. edt Carpenter, David E. edt Erscheint auch als Druck-Ausgabe 9781461362968 Erscheint auch als Druck-Ausgabe 9780306445675 Erscheint auch als Druck-Ausgabe 9781461529798 https://doi.org/10.1007/978-1-4615-2978-1 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Advances in Neutron Capture Therapy Pathology Pharmacology/Toxicology Nuclear Medicine Ultrasound Biochemistry, general Biotechnology Toxicology Nuclear medicine Diagnosis, Ultrasonic Biochemistry Neutroneneinfangtherapie (DE-588)4596398-8 gnd |
| subject_GND | (DE-588)4596398-8 (DE-588)1071861417 |
| title | Advances in Neutron Capture Therapy |
| title_auth | Advances in Neutron Capture Therapy |
| title_exact_search | Advances in Neutron Capture Therapy |
| title_full | Advances in Neutron Capture Therapy edited by Albert H. Soloway, Rolf F. Barth, David E. Carpenter |
| title_fullStr | Advances in Neutron Capture Therapy edited by Albert H. Soloway, Rolf F. Barth, David E. Carpenter |
| title_full_unstemmed | Advances in Neutron Capture Therapy edited by Albert H. Soloway, Rolf F. Barth, David E. Carpenter |
| title_short | Advances in Neutron Capture Therapy |
| title_sort | advances in neutron capture therapy |
| topic | Pathology Pharmacology/Toxicology Nuclear Medicine Ultrasound Biochemistry, general Biotechnology Toxicology Nuclear medicine Diagnosis, Ultrasonic Biochemistry Neutroneneinfangtherapie (DE-588)4596398-8 gnd |
| topic_facet | Pathology Pharmacology/Toxicology Nuclear Medicine Ultrasound Biochemistry, general Biotechnology Toxicology Nuclear medicine Diagnosis, Ultrasonic Biochemistry Neutroneneinfangtherapie Konferenzschrift 1992 Columbus Ohio |
| url | https://doi.org/10.1007/978-1-4615-2978-1 |
| work_keys_str_mv | AT solowayalberth advancesinneutroncapturetherapy AT barthrolff advancesinneutroncapturetherapy AT carpenterdavide advancesinneutroncapturetherapy |